Fulgent Genetics

From Verify.Wiki
Jump to: navigation, search
Fulgent Genetics
Type Public
Industry Biotechnology
Founded 2011
Headquarters Temple City, California 91780 United States
Key people Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO) Cite error: Closing </ref> missing for <ref> tag

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

  • Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
  • College of American Pathologists (CAP) Accreditation 2017
  • California Clinical Laboratory License 2016
  • Florida Clinical Laboratory License 2016 - 2018
  • Pennsylvania Clinical Laboratory Permit 2016-2017
  • Maryland Medical Laboratory License 2015-2016



Top 5 Recent Tweets

September 19, 2018ConsumerFeedZacks: Fulgent Genetics Inc $FLGT Given Consensus Rating of “Hold” by Brokerages https://t.co/2pRh0vPiqo
September 17, 2018registrarjournZacks: Fulgent Genetics Inc $FLGT Receives Average Rating of “Hold” from Analysts https://t.co/b5wZPSiv5h
September 17, 2018EnterpriseLeadeZacks: Fulgent Genetics Inc $FLGT Receives Average Rating of “Hold” from Analysts https://t.co/taOchdnHWv
September 14, 2018registrarjournFulgent Genetics $FLGT Earning Somewhat Positive Media Coverage, Study Shows https://t.co/u3PuKAlhvd

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history